 Uterine Cervical Neoplasms
"Uterine Cervical Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the UTERINE CERVIX.
| Descriptor ID |
D002583
|
| MeSH Number(s) |
C04.588.945.418.948.850 C13.351.500.852.593.131 C13.351.500.852.762.850 C13.351.937.418.875.850
|
| Concept/Terms |
Uterine Cervical Neoplasms- Uterine Cervical Neoplasms
- Cervical Neoplasm, Uterine
- Cervical Neoplasms, Uterine
- Neoplasm, Uterine Cervical
- Neoplasms, Uterine Cervical
- Uterine Cervical Neoplasm
- Neoplasms, Cervical
- Cervical Neoplasms
- Cervical Neoplasm
- Neoplasm, Cervical
- Neoplasms, Cervix
- Cervix Neoplasms
- Cervix Neoplasm
- Neoplasm, Cervix
Cancer of the Uterine Cervix- Cancer of the Uterine Cervix
- Cancer of the Cervix
- Cervical Cancer
- Uterine Cervical Cancer
- Cancer, Uterine Cervical
- Cancers, Uterine Cervical
- Cervical Cancer, Uterine
- Cervical Cancers, Uterine
- Uterine Cervical Cancers
- Cancer of Cervix
- Cervix Cancer
- Cancer, Cervix
- Cancers, Cervix
|
Below are MeSH descriptors whose meaning is more general than "Uterine Cervical Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Uterine Cervical Neoplasms".
This graph shows the total number of publications written about "Uterine Cervical Neoplasms" by people in this website by year, and whether "Uterine Cervical Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1991 | 2 | 0 | 2 | | 1992 | 1 | 0 | 1 | | 1994 | 4 | 0 | 4 | | 1995 | 2 | 0 | 2 | | 1996 | 1 | 3 | 4 | | 1997 | 1 | 0 | 1 | | 1998 | 2 | 0 | 2 | | 1999 | 2 | 0 | 2 | | 2000 | 1 | 0 | 1 | | 2001 | 6 | 1 | 7 | | 2002 | 5 | 2 | 7 | | 2003 | 2 | 1 | 3 | | 2004 | 3 | 2 | 5 | | 2005 | 2 | 0 | 2 | | 2006 | 0 | 1 | 1 | | 2007 | 5 | 1 | 6 | | 2008 | 3 | 0 | 3 | | 2009 | 2 | 2 | 4 | | 2010 | 5 | 2 | 7 | | 2011 | 8 | 2 | 10 | | 2012 | 8 | 0 | 8 | | 2013 | 12 | 0 | 12 | | 2014 | 6 | 3 | 9 | | 2015 | 7 | 3 | 10 | | 2016 | 8 | 3 | 11 | | 2017 | 17 | 3 | 20 | | 2018 | 8 | 2 | 10 | | 2019 | 6 | 0 | 6 | | 2020 | 5 | 0 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Uterine Cervical Neoplasms" by people in Profiles.
-
Hoss M, Lyon C. PURL: Do-it-yourself cervical cancer screening? J Fam Pract. 2020 Jul/Aug; 69(6):306-308.
-
McMellen A, Woodruff ER, Corr BR, Bitler BG, Moroney MR. Wnt Signaling in Gynecologic Malignancies. Int J Mol Sci. 2020 Jun 16; 21(12).
-
Abu-Rustum NR, Yashar CM, Bean S, Bradley K, Campos SM, Chon HS, Chu C, Cohn D, Crispens MA, Damast S, Fisher CM, Frederick P, Gaffney DK, Giuntoli R, Han E, Huh WK, Lurain Iii JR, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Fader AN, Remmenga SW, Reynolds RK, Sisodia R, Tillmanns T, Ueda S, Urban R, Wyse E, McMillian NR, Motter AD. NCCN Guidelines Insights: Cervical Cancer, Version 1.2020. J Natl Compr Canc Netw. 2020 06; 18(6):660-666.
-
Chase D, Huang HQ, Monk BJ, Ramondetta LM, Penson RT, Gil K, Landrum LM, Leitao M, Oaknin A, Huh WK, Pulaski HL, Robison K, Guntupalli SR, Richardson D, Salani R, Sill MW, Wenzel LB, Tewari KS. Patient-reported outcomes at discontinuation of anti-angiogenesis therapy in the randomized trial of chemotherapy with bevacizumab for advanced cervical cancer: an NRG Oncology Group study. Int J Gynecol Cancer. 2020 05; 30(5):596-601.
-
Sabik LM, Vichare AM, Dahman B, Bradley CJ. Co-payment policies and breast and cervical cancer screening in Medicaid. Am J Manag Care. 2020 02; 26(2):69-74.
-
Cataldi JR, Håbesland M, Anderson-Mellies A, Dempsey AF, Cockburn M. The potential population-based impact of an HPV vaccination intervention in Colorado. Cancer Med. 2020 02; 9(4):1553-1561.
-
Ward K, Ramzan A, Sheeder J, Fischer S, Lefkowits C. Persistent opioid use after radiation therapy in opioid-naive cervical cancer survivors. Int J Gynecol Cancer. 2019 09; 29(7):1105-1109.
-
Papasavvas E, Kossenkov AV, Azzoni L, Zetola NM, Mackiewicz A, Ross BN, Fair M, Vadrevu S, Ramogola-Masire D, Sanne I, Firnhaber C, Montaner LJ. Gene expression profiling informs HPV cervical histopathology but not recurrence/relapse after LEEP in ART-suppressed HIV+HPV+ women. Carcinogenesis. 2019 04 29; 40(2):225-233.
-
Shukla S, Bjerke GA, Muhlrad D, Yi R, Parker R. The RNase PARN Controls the Levels of Specific miRNAs that Contribute to p53 Regulation. Mol Cell. 2019 03 21; 73(6):1204-1216.e4.
-
Amini A, Robin TP, Rusthoven CG, Schefter TE, Akhavan D, Chen YJ, Glaser SM, Corr BR, Ashing KT, Fisher CM. Disparities Predict for Higher Rates of Cut-through Hysterectomies in Locally Advanced Cervical Cancer. Am J Clin Oncol. 2019 01; 42(1):21-26.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|